Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

about

P2860

Q52590996-25BAC5A5-8342-4D0F-84CF-8E7B16FBC292

P2860

Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

Item

http://www.wikidata.org/entity/Q38911031

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Glucose-regulated protein 78 m ...... ractory prostate cancer cells.

@en

type

Item

label

Glucose-regulated protein 78 m ...... ractory prostate cancer cells.

@en

prefLabel

Glucose-regulated protein 78 m ...... ractory prostate cancer cells.

@en

P1476

Glucose-regulated protein 78 m ...... fractory prostate cancer cells

@en

P2093

Chien-Yu Huang

http://www.w3.org/2001/XMLSchema#string

Chun-Te Wu

http://www.w3.org/2001/XMLSchema#string

Feng-Yen Lin

http://www.w3.org/2001/XMLSchema#string

Li-Jen Kuo

http://www.w3.org/2001/XMLSchema#string

Ming-Te Huang

http://www.w3.org/2001/XMLSchema#string

Wan-Li Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular determinants of resistance to antiandrogen therapy

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Androgen receptor in prostate cancer

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.

Alkannin, HSP70 inducer, protects against UVB-induced apoptosis in human keratinocytes.

Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission.

Cellular pharmacology studies of shikonin derivatives.

Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).

Effect of β,β-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo.

P2888

s13277-015-3157-0

P304

5063-5070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3157-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yu-Jia Chang

Chin-Sheng Hung

P577

2015-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019504967

http://www.w3.org/2001/XMLSchema#string

P698

25669168

http://www.w3.org/2001/XMLSchema#string

P921

glycobiology

Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

about

P2860

P2860

Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921